Calgary, Canada–(ENEWSPF)–September 212, 2012. The oral administration of the synthetic THC analogue nabilone (brand name: Cesamet) mitigates neuropathic pain and is well tolerated, according to clinical trial data published online by the scientific journal Pain.
Investigators at the University of Calgary, Department of Neurosciences assessed the use of nabiloneversus placebo in patients with diabetic neuropathy (nerve pain) in a randomize, double-blind, placebo-controlled trial. Researchers administered daily oral doses of nabilone to 37 participants in…
